Pathos AI, Inc.
New Form D on file · 2026-11-19 · the record
Before you sell to, join or invest in Pathos AI, Inc.
MentionFox check on Pathos AI, Inc.: only 1 source on file so far (checked 20 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pathos-ai-inc-form-d-000002
Check Pathos AI, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Pathos AI, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-19.
Pathos AI, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 19, 2026. The filing reports $237.52M sold. Its industry group is Biotechnology. It names Iker Huerga (Executive Officer, Director), Alex Dolan (Executive Officer), Eric Lefkofsky (Director) (SEC Form D, November 19, 2026).
In its own words: “Pathos integrates AI technology, biological modeling, and the largest collection of oncology patient data to make clinical trials smarter and more precise.” (pathos.com, checked November 8, 2026)
Sell to companies like Pathos AI, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Pathos AI, Inc. raised on Nov 19. 137 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Linework USA INC. | $1.2B | AI and software |
| Linework USA INC. | $326M | AI and software |
| Pathos AI, Inc. | $238M | Biotech |
| Galvanize Therapeutics, Inc. | $136M | Biotech |
| Tractian Inc. | $106M | AI and software |
Selling to Pathos AI, Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.
Is this your company?
New Form D on file · 2026-11-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Pathos AI, Inc.
Free to see. No signup.
More on the people and the money behind Pathos AI, Inc., from the filings we hold.
Biotechnology raises filed within 90 days of this one, largest first.
Get an email when Pathos AI, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Pathos AI, Inc. raises, hires or launches. No email unless you switch it on.
Watch Pathos AI, Inc. →Get the full cited report on Pathos AI, Inc.
What the filing shows about Pathos AI, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Pathos AI, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Pathos AI, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Pathos AI, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Pathos AI, Inc.'s address as 600 W. Chicago Ave., Suite 510, Chicago, IL 60654.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Pathos AI, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Pathos AI, Inc. is a registered filer with the SEC (CIK 1967854) and has filed since 2023-03-02. 4 filings are on record, the latest on 2026-11-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Pathos AI, Inc.'s Form D of 2026-11-19 names Iker Huerga, Alex Dolan, Eric Lefkofsky and 4 more as its officers, directors or promoters.
Its new offerings report $602.52M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 760 filings in Biotechnology, totalled by week. The dot is this raise, $237.52M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Iker Huerga is named as Executive Officer and Director on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Alex Dolan is named as Executive Officer on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Eric Lefkofsky is named as Director on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Ryan Fukushima is named as Director on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Mohamad Makhzoumi is named as Director on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Tyrell Rivers is named as Director on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
Mike Mauceri is named as Executive Officer on the Form D that Pathos AI, Inc. filed with the SEC on 19 November 2026, one of 7 people that filing names.
7 people named on the filing — 3 holding an executive role and 4 as directors only.
Named as of the 2026-11-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Pathos AI, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Pathos AI, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Pathos AI, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
7 people named on this filing See who they are
Start a free 5-day trial →You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pathos AI, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Pathos AI, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-11-16 · Biotech raises in Chicago
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/pathos-ai-inc-form-d-000002